T

TherapeuticsMD
D

TXMD

1.66000
USD
-0.1
(-5.68%)
مغلق
حجم التداول
1
الربح لكل سهم
0
العائد الربحي
0
P/E
-4
حجم السوق
17,759,945
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    4.380
    (2.36%)
    189.700 USD
    B
    BHC
    0.07000
    (1.16%)
    6.10000 USD
    C
    CRBP
    -0.500
    (-0.84%)
    59.160 USD
    GSK
    0.865
    (2.23%)
    39.650 USD
    JNJ
    2.930
    (1.86%)
    160.770 USD
    MRK
    0.680
    (0.60%)
    113.800 USD
    PFE
    0.115
    (0.38%)
    30.650 USD
    T
    TEVA
    0.100
    (0.57%)
    17.530 USD
الأخبار
المقالات

العنوان: TherapeuticsMD

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.